Rapid Testing for Carbapenamase Producing Enterobacteriaceae

Multi-drug resistance bacteria are a global threat to public health and have been associated with high mortality rates among those patients receiving long term acute care. In order to improve public health and provide information for infection control and prevention, there is an urgent need for rapid diagnostic tests that allow stratification of those patients carrying resistant bacteria.

Rapid Testing for Carbapenamase Producing Enterobacteriaceae: Case Study

Links to the Innovation Pathway: Markets; Finance; Clinical Trials; Evaluation; Commercialisation; Brokering

(Uploaded on 10th August 2016)

Search the Innovation Exchange